EC-NAPROSYN Drug Patent Profile
✉ Email this page to a colleague
When do Ec-naprosyn patents expire, and when can generic versions of Ec-naprosyn launch?
Ec-naprosyn is a drug marketed by Atnahs Pharma Us and is included in one NDA.
The generic ingredient in EC-NAPROSYN is naproxen. There are forty-two drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the naproxen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ec-naprosyn
A generic version of EC-NAPROSYN was approved as naproxen by GRANULES on December 21st, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EC-NAPROSYN?
- What are the global sales for EC-NAPROSYN?
- What is Average Wholesale Price for EC-NAPROSYN?
Summary for EC-NAPROSYN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 135 |
| Clinical Trials: | 44 |
| Patent Applications: | 2,141 |
| Drug Prices: | Drug price information for EC-NAPROSYN |
| DailyMed Link: | EC-NAPROSYN at DailyMed |
Recent Clinical Trials for EC-NAPROSYN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Northwestern Medical Group | Phase 2 |
| Shirley Ryan AbilityLab | Phase 2 |
| Western University, Canada | N/A |
Pharmacology for EC-NAPROSYN
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for EC-NAPROSYN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Atnahs Pharma Us | EC-NAPROSYN | naproxen | TABLET, DELAYED RELEASE;ORAL | 020067-002 | Oct 14, 1994 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Atnahs Pharma Us | EC-NAPROSYN | naproxen | TABLET, DELAYED RELEASE;ORAL | 020067-003 | Oct 14, 1994 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
